Piramal Pharma Ltd 11 May 2024 12:00 AM
Board of Piramal Pharma recommends final dividend,
Piramal Pharma announced that the Board of Directors of the Company at its meeting held on 10 May 2024, inter alia, have recommended the final dividend of Rs 0.11 per equity Share (i.e. 1.1%) , subject to the approval of the shareholders.Powered by Capital Market - Live News
Piramal Pharma Ltd 11 May 2024 12:00 AM
Piramal Pharma consolidated net profit rises 102.10% in the March 2024 quarter,
Net profit of Piramal Pharma rose 102.10% to Rs 101.27 crore in the quarter ended March 2024 as against Rs 50.11 crore during the previous quarter ended March 2023. Sales rose 17.97% to Rs 2552.36 crore in the quarter ended March 2024 as against Rs 2163.58 crore during the previous quarter ended March 2023.For the full year,net profit reported to Rs 17.82 crore in the year ended March 2024 as against net loss of Rs 186.46 crore during the previous year ended March 2023. Sales rose 15.39% to Rs 8171.16 crore in the year ended March 2024 as against Rs 7081.55 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales2552.362163.58 18 8171.167081.55 15 OPM %20.7616.24 -14.648.87 - PBDT454.13279.30 63 982.65563.50 74 PBT258.0094.89 172 242.08-113.19 LP NP101.2750.11 102 17.82-186.46 LP Powered by Capital Market - Live News
Piramal Pharma Ltd 02 May 2024 12:00 AM
Piramal Pharma to convene board meeting,
Piramal Pharma will hold a meeting of the Board of Directors of the Company on 10 May 2024.Powered by Capital Market - Live News
Piramal Pharma Ltd 10 Apr 2024 12:00 AM
Piramal Pharma forays into men`s grooming market in India with launch of BOHEM,
Piramal Pharma announced its foray into men`s personal grooming category with the launch of BOHEM product range. This includes a Hair Removal Spray, a Beard Growth Oil, and an Underarm Roll-On. With BOHEM, Piramal Pharma intends to shift the grooming culture among men towards more inclusive self-care routines, leveraging scientifically proven ingredients for tangible results.Powered by Capital Market - Live News
Piramal Pharma Ltd 31 Jan 2024 12:00 AM
Piramal Pharma reports standalone net profit of Rs 74.34 crore in the December 2023 quarter,
Net profit of Piramal Pharma reported to Rs 74.34 crore in the quarter ended December 2023 as against net loss of Rs 2.42 crore during the previous quarter ended December 2022. Sales rose 25.93% to Rs 1024.14 crore in the quarter ended December 2023 as against Rs 813.29 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales1024.14813.29 26 OPM %12.263.35 - PBDT141.2247.93 195 PBT89.660.74 12016 NP74.34-2.42 LP Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now